A.RBC4.0×1012/L,Hb75g/L,MCV63fl,MCH22pg,MCHC0.25,網(wǎng)織紅細(xì)胞0.010
B.RBC2.3×1012/L,Hb85g/L,MCV94fl,MCH35pg,MCHC0.35,網(wǎng)織紅細(xì)胞0.015
C.RBC2.0×1012/L,Hb60g/L,MCV84fl,MCH30pg,MCHC0.33,網(wǎng)織紅細(xì)胞0.003
D.RBC4.5×1012/L,Hb115g/L,MCV83fl,MCH31pg,MCHC0.34,網(wǎng)織紅細(xì)胞0.015
E.RBC2.2×1012/L,Hb63g/L,MCV81fl,MCH32pg,MCHC0.33,網(wǎng)織紅細(xì)胞0.09
您可能感興趣的試卷
你可能感興趣的試題
A.RBC4.0×1012/L,Hb75g/L,MCV63fl,MCH22pg,MCHC0.25,網(wǎng)織紅細(xì)胞0.010
B.RBC2.3×1012/L,Hb85g/L,MCV94fl,MCH35pg,MCHC0.35,網(wǎng)織紅細(xì)胞0.015
C.RBC2.0×1012/L,Hb60g/L,MCV84fl,MCH30pg,MCHC0.33,網(wǎng)織紅細(xì)胞0.003
D.RBC4.5×1012/L,Hb115g/L,MCV83fl,MCH31pg,MCHC0.34,網(wǎng)織紅細(xì)胞0.015
E.RBC2.2×1012/L,Hb63g/L,MCV81fl,MCH32pg,MCHC0.33,網(wǎng)織紅細(xì)胞0.09
A.RBC4.0×1012/L,Hb75g/L,MCV63fl,MCH22pg,MCHC0.25,網(wǎng)織紅細(xì)胞0.010
B.RBC2.3×1012/L,Hb85g/L,MCV94fl,MCH35pg,MCHC0.35,網(wǎng)織紅細(xì)胞0.015
C.RBC2.0×1012/L,Hb60g/L,MCV84fl,MCH30pg,MCHC0.33,網(wǎng)織紅細(xì)胞0.003
D.RBC4.5×1012/L,Hb115g/L,MCV83fl,MCH31pg,MCHC0.34,網(wǎng)織紅細(xì)胞0.015
E.RBC2.2×1012/L,Hb63g/L,MCV81fl,MCH32pg,MCHC0.33,網(wǎng)織紅細(xì)胞0.09
A.血紅蛋白測(cè)定
B.血清鐵蛋白測(cè)定
C.紅細(xì)胞游離原卟啉測(cè)定
D.血清鐵測(cè)定
E.血清總鐵結(jié)合力
A.血紅蛋白測(cè)定
B.血清鐵蛋白測(cè)定
C.紅細(xì)胞游離原卟啉測(cè)定
D.血清鐵測(cè)定
E.血清總鐵結(jié)合力
A.紅細(xì)胞形態(tài)為小細(xì)胞
B.紅細(xì)胞形態(tài)為小細(xì)胞低色素
C.紅細(xì)胞形態(tài)為正細(xì)胞正色素
D.紅細(xì)胞形態(tài)為小細(xì)胞高色素
E.紅細(xì)胞形態(tài)為大細(xì)胞
最新試題
下列有關(guān)蠶豆病的描述哪一項(xiàng)正確()
大劑量甲氨蝶呤靜脈注射后用哪種藥物解救治療()
下列哪一項(xiàng)有關(guān)營(yíng)養(yǎng)性巨幼細(xì)胞貧血的治療是正確的()
診斷慢性ITP的主要根據(jù)為有ITP表現(xiàn)且病程超過(guò)()
小兒惡性淋巴瘤骨髓受累,伴淋巴結(jié)腫大屬于哪一臨床分期()
口服鐵劑治療時(shí)采取下列哪一項(xiàng)措施能夠促進(jìn)鐵的吸收()
考慮組織細(xì)胞壞死性淋巴結(jié)炎診斷主要依據(jù)()
小兒霍奇金病多數(shù)起源于()
下列哪項(xiàng)檢查對(duì)霍奇金病具有確診意義()
組織細(xì)胞壞死性淋巴結(jié)炎的主要治療是()